Related Experiment Video

Updated: May 6, 2026

Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

10.8K

Juvenile idiopathic arthritis - what the clinician needs to know

Philip J Kahn

    Bulletin of the Hospital for Joint Disease (2013)
    |October 25, 2013
    PubMed

    Insights

    Juvenile idiopathic arthritis (JIA) is a common childhood rheumatic disease causing joint pain and deformity. Newer biologic treatments offer targeted, better-tolerated therapies for this chronic condition.

    Area of Science:

    • Pediatric rheumatology
    • Immunology
    • Translational medicine

    Background:

    • Juvenile idiopathic arthritis (JIA) is a prevalent chronic childhood arthritis with unknown etiology.
    • It can lead to significant joint damage, deformity, and growth issues, potentially persisting into adulthood.
    • Previous treatments lacked specificity and carried substantial adverse effects.

    Purpose of the Study:

    • To review the clinical characteristics of JIA.
    • To provide an update on the latest therapeutic strategies for JIA.

    Main Methods:

    • Literature review of clinical features and treatment advancements in JIA.
    • Analysis of current research on targeted therapies and biologics.

    Main Results:

    • JIA presents with diverse clinical manifestations and varying prognoses.
    • Biologic agents represent a significant advancement, offering targeted and potentially safer treatment options.
    • Ongoing research aims to elucidate disease mechanisms for improved therapies.

    Conclusions:

    • Understanding JIA's clinical spectrum is crucial for effective management.
    • Biologics are transforming JIA treatment, improving patient outcomes.
    • Continued research holds promise for more effective treatments and potential cures for JIA.

    More Related Videos

    Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue09:18

    Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

    Published on: February 24, 2023

    8.4K
    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients02:28

    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

    Published on: March 1, 2024

    1.1K

    Related Concept Videos

    The JAK-STAT Signaling Pathway01:20

    The JAK-STAT Signaling Pathway

    Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
    10.3K
    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

    The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
    1.3K
    Inflammatory Bowel Disease IV: Clinical Manifestations01:20

    Inflammatory Bowel Disease IV: Clinical Manifestations

    Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
    64
    Rheumatic Heart Disease I: Introduction01:23

    Rheumatic Heart Disease I: Introduction

    Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
    1.0K
    Chronic Inflammation: Introduction01:12

    Chronic Inflammation: Introduction

    Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
    51
    Pericarditis I: Introduction01:22

    Pericarditis I: Introduction

    Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
    762